Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

NT5E mutations and arterial calcifications. N Engl J Med (2011) 8.71

Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 3.64

Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res (2009) 3.53

Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet (2012) 3.34

Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15

Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab (2011) 2.65

Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res (2008) 2.19

The emerging role of phosphate in vascular calcification. Kidney Int (2009) 2.14

Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet (2011) 2.02

A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res (2011) 2.00

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet (2010) 1.93

Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet (2008) 1.93

Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet (2010) 1.65

Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res (2011) 1.46

Medial vascular calcification revisited: review and perspectives. Eur Heart J (2014) 1.44

Generalized arterial calcification of infancy: treatment with bisphosphonates. Nat Clin Pract Endocrinol Metab (2009) 1.43

Vascular calcification and osteoporosis--from clinical observation towards molecular understanding. Osteoporos Int (2006) 1.42

The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One (2011) 1.40

Generalized arterial calcification of infancy: two siblings with prolonged survival. Eur J Pediatr (2005) 1.32

ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci U S A (2013) 1.31

Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up. Eur J Pediatr (2006) 1.27

Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin. Front Genet (2012) 1.21

Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol (2010) 1.20

Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice. PLoS One (2012) 1.18

The expanding family of hypophosphatemic syndromes. J Bone Miner Metab (2011) 1.14

Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal (2006) 1.12

Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J Biomol Screen (2009) 1.12

Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy: genotypic overlap with pseudoxanthoma elasticum. J Invest Dermatol (2013) 1.10

Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal (2006) 1.07

Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. Eur J Pediatr (2011) 1.06

Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling. Proc Natl Acad Sci U S A (2012) 1.05

A large-scale genetic association study of ossification of the posterior longitudinal ligament of the spine. Hum Genet (2006) 1.04

Inorganic pyrophosphatase induces type I collagen in osteoblasts. Bone (2009) 1.04

Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Arthritis Res Ther (2005) 1.01

Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01

Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment. Intractable Rare Dis Res (2015) 0.98

Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol (2010) 0.98

Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization. Blood (2015) 0.98

Characterization of conserved and nonconserved imprinted genes in swine. Biol Reprod (2009) 0.98

Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification. J Bone Miner Metab (2006) 0.98

Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol (2009) 0.98

Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol (2013) 0.98

Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg (2007) 0.96

Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation. J Biol Chem (2011) 0.96

Genetic pathways of vascular calcification. Trends Cardiovasc Med (2012) 0.94

Fibroblast involvement in soft connective tissue calcification. Front Genet (2013) 0.94

A protective role for FGF-23 in local defence against disrupted arterial wall integrity? Mol Cell Endocrinol (2013) 0.94

Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. Am J Physiol Cell Physiol (2009) 0.93

Phosphate sensing. Adv Chronic Kidney Dis (2011) 0.93

The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene. Cell Cycle (2015) 0.93

Ectopic mineralization disorders of the extracellular matrix of connective tissue: molecular genetics and pathomechanisms of aberrant calcification. Matrix Biol (2013) 0.92

Cholesterol in vascular and valvular calcification. Circulation (2001) 0.92

FGF23 and syndromes of abnormal renal phosphate handling. Adv Exp Med Biol (2012) 0.92

Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol (2005) 0.91

Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE). Dis Model Mech (2014) 0.91

Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis in zebrafish. Proc Natl Acad Sci U S A (2012) 0.91

Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion/insertion mutation in the Enpp1 gene. PLoS One (2014) 0.90

Npp1 promotes atherosclerosis in ApoE knockout mice. J Cell Mol Med (2011) 0.90

Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res (2015) 0.90

Arterial calcification is driven by RAGE in Enpp1-/- mice. J Vasc Res (2010) 0.89

Hypophosphatemia and growth. Pediatr Nephrol (2012) 0.88

Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Sci Rep (2016) 0.88

Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity. BMC Genomics (2014) 0.87

Molecular diagnosis of generalized arterial calcification of infancy (GACI). J Cardiovasc Dis Res (2012) 0.86

Assay format as a critical success factor for identification of novel inhibitor chemotypes of tissue-nonspecific alkaline phosphatase from high-throughput screening. Molecules (2010) 0.86

Upregulation of IGF2 expression during vascular calcification. J Mol Endocrinol (2014) 0.86

Genetic disorders of phosphate regulation. Pediatr Nephrol (2012) 0.86

ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy. Nat Commun (2015) 0.86

The role of midkine in skeletal remodelling. Br J Pharmacol (2014) 0.84

Expression of NPP1 is regulated during atheromatous plaque calcification. J Cell Mol Med (2011) 0.84

Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1. JIMD Rep (2011) 0.84

N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models. PLoS One (2015) 0.83

It ANKH necessarily so. J Clin Endocrinol Metab (2011) 0.82

Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia. Periodontol 2000 (2013) 0.82

Expression, purification, crystallization and preliminary X-ray crystallographic analysis of Enpp1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.82

"Missing" inhibitors of calcification: general aspects and implications in renal failure. Pediatr Nephrol (2004) 0.82

Molecular basis of purinergic signal metabolism by ectonucleotide pyrophosphatase/phosphodiesterases 4 and 1 and implications in stroke. J Biol Chem (2013) 0.82

Atrium of stone: A case of confined left atrial calcification without hemodynamic compromise. World J Clin Cases (2014) 0.82

Ectopic mineralization of cartilage and collagen-rich tendons and ligaments in Enpp1asj-2J mice. Oncotarget (2016) 0.81

Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease. World J Nephrol (2012) 0.80

Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80

Enpp1: a potential facilitator of breast cancer bone metastasis. PLoS One (2013) 0.80

Genomic study of ossification of the posterior longitudinal ligament of the spine. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.80

Alkalosis and Dialytic Clearance of Phosphate Increases Phosphatase Activity: A Hidden Consequence of Hemodialysis. PLoS One (2016) 0.79

The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification. BMC Pediatr (2013) 0.79

Role of CD73 and extracellular adenosine in disease : Presented by Maria P. Abbracchio. Purinergic Signal (2011) 0.79

From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders. World J Clin Cases (2015) 0.79

Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1. Hybridoma (Larchmt) (2011) 0.79

A new Enpp1 allele, Enpp1(ttw-Ham), identified in an ICR closed colony. Exp Anim (2014) 0.79

Sonological appearance of idiopathic arterial calcification in fetus: A rare case. Indian J Radiol Imaging (2009) 0.78

Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1. Bioorg Med Chem Lett (2014) 0.78

Genetic heterogeneity of pseudoxanthoma elasticum: the Chinese signature profile of ABCC6 and ENPP1 mutations. J Invest Dermatol (2015) 0.78

Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). PLoS One (2011) 0.78

Hepatic ENPP1 expression is induced in diabetic rabbits. Mamm Genome (2006) 0.78

New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers. Front Genet (2013) 0.78

Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models. Int J Biol Sci (2012) 0.77

Large animal models of cardiovascular disease. Cell Biochem Funct (2016) 0.77

Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification. Am J Med Genet A (2016) 0.77

Calpain-1 Mediated Disorder of Pyrophosphate Metabolism Contributes to Vascular Calcification Induced by oxLDL. PLoS One (2015) 0.77

Dual Effects of Bisphosphonates on Ectopic Skin and Vascular Soft Tissue Mineralization versus Bone Microarchitecture in a Mouse Model of Generalized Arterial Calcification of Infancy. J Invest Dermatol (2016) 0.76

A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet (2010) 6.62

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med (2010) 6.39

15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet (2006) 5.29

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22

Chronic lung disease after premature birth. N Engl J Med (2007) 5.10

Correlation between genetic and geographic structure in Europe. Curr Biol (2008) 5.02

Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A (2011) 4.27

Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A (2002) 4.22

Swallowed partial dentures. J R Soc Med (2004) 4.01

HaploPainter: a tool for drawing pedigrees with complex haplotypes. Bioinformatics (2004) 4.00

Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet (2010) 3.99

Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat Genet (2011) 3.99

Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96

HomozygosityMapper--an interactive approach to homozygosity mapping. Nucleic Acids Res (2009) 3.86

Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet (2010) 3.60

Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol (2012) 3.29

CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat Genet (2010) 3.25

Congenital glutamine deficiency with glutamine synthetase mutations. N Engl J Med (2005) 3.24

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21

A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet (2002) 3.19

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18

Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15

A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet (2009) 3.06

Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet (2007) 3.02

G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet (2008) 3.00

Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet (2004) 2.94

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet (2013) 2.91

ALOHOMORA: a tool for linkage analysis using 10K SNP array data. Bioinformatics (2005) 2.90

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83

Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet (2005) 2.83

Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev (2009) 2.76

A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet (2007) 2.75

Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet (2007) 2.74

Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am J Hum Genet (2008) 2.74

Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet (2005) 2.70

ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64

Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res (2008) 2.64

Comprehensive mutational screening in a cohort of Danish families with hereditary congenital cataract. Invest Ophthalmol Vis Sci (2009) 2.54

Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol (2004) 2.50

Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum (2005) 2.48

Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet (2007) 2.46

Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet (2004) 2.45

Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy. Nat Genet (2004) 2.40

Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet (2010) 2.39

A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution. Am J Hum Genet (2002) 2.34

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology (2013) 2.32

Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A (2006) 2.31

tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet (2008) 2.28

Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet (2005) 2.21

COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21

Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet (2011) 2.16

Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood (2002) 2.15

Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. N Engl J Med (2016) 2.15

Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet (2010) 2.14

A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation (2003) 2.12

Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects. Am J Hum Genet (2009) 2.10

Identification of mutations in CUL7 in 3-M syndrome. Nat Genet (2005) 2.10

Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest (2002) 2.09

Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am J Hum Genet (2009) 2.09

Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med (2009) 2.08

The Research Associate Committee of the ACR Imaging Network. J Am Coll Radiol (2006) 2.08

Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis (2002) 2.07

Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet (2004) 2.03

Mutations of the CEP290 gene encoding a centrosomal protein cause Meckel-Gruber syndrome. Hum Mutat (2008) 2.03

Wnt signaling and Dupuytren's disease. N Engl J Med (2011) 2.02

Genome-wide analysis indicates more Asian than Melanesian ancestry of Polynesians. Am J Hum Genet (2008) 2.02

Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet (2011) 2.02

Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00

Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol (2009) 1.96

Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet (2010) 1.93

Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. Science (2008) 1.93

Demographic history of Oceania inferred from genome-wide data. Curr Biol (2010) 1.93

Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet (2012) 1.93

Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet (2008) 1.93

Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation (2008) 1.92

Recessive HYDIN mutations cause primary ciliary dyskinesia without randomization of left-right body asymmetry. Am J Hum Genet (2012) 1.91

Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet (2009) 1.89

Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum Mutat (2010) 1.88

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation (2005) 1.87

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest (2010) 1.85

Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res (2003) 1.83

Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med (2010) 1.81

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet (2006) 1.79

Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2012) 1.78

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77

Mutations in different components of FGF signaling in LADD syndrome. Nat Genet (2006) 1.76

Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain (2010) 1.76

The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS One (2008) 1.76